Abstract

Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer: Erratum.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
MS19.01 Drug-Induced Pneumonitis with IO: How worried should we be for our Lung Cancer Patients
D Hao
Journal of Thoracic Oncology | VOL. 13
D HaoD Hao
01 Oct 2018
442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer
Alexander Wong ... Jessica Zimmer
Journal for ImmunoTherapy of Cancer | VOL. 10
Alexander Wong, et. al.Alexander Wong ... Jessica Zimmer
01 Nov 2022
804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors
Bruce Tiu ... Meghan Mooradian
Journal for ImmunoTherapy of Cancer | VOL. 9
Bruce Tiu, et. al.Bruce Tiu ... Meghan Mooradian
01 Nov 2021
Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer.
Haitao Tao ... Francesco Passiglia
Translational lung cancer research | VOL. 11
Haitao Tao, et. al.Haitao Tao ... Francesco Passiglia
01 Mar 2022
View more papers

More From: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy

Paper Title
Journal
Date
Author
Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors.
James Yu ... Richard Kim
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
James Yu, et. al.James Yu ... Richard Kim
16 Jul 2024
HES6 Mediates Oxidative Phosphorylation Pathway to Promote Immune Infiltration of CD8+ T Cells in Lung Adenocarcinoma.
Zhoumiao Chen ... Zhao Chen
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
Zhoumiao Chen, et. al.Zhoumiao Chen ... Zhao Chen
15 Jul 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
David J Einstein ... David F Mcdermott
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
David J Einstein, et. al.David J Einstein ... David F Mcdermott
15 Jul 2024
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors.
Giulia Mazzaschi ... Sebastiano Buti
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
Giulia Mazzaschi, et. al.Giulia Mazzaschi ... Sebastiano Buti
11 Jul 2024
View more papers